The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review

被引：0

作者：

Torgashina, A. V. ^{[1
]}

Vasilyev, V. I. ^{[1
]}

机构：

[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia

来源：

TERAPEVTICHESKII ARKHIV | 2018年 / 90卷 / 05期

关键词：

neuromyelitis optica spectrum disorder; Sjogren's syndrome; rituximab; SPECTRUM DISORDERS; MANIFESTATIONS; NEUTROPENIA; INVOLVEMENT; MYELOPATHY; DISEASE;

D O I：

10.26442/terarkh201890576-80

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This case is the first description of the successful anti-B-cell therapy with rituximab in a patient with Sjogren's syndrome and neuromyelitis optica spectrum disorder in Russia. This article contains the literature data on clinical manifestations and methods of the diagnosis of neuromyelitis optica spectrum disorder. Furthermore, contemporary view on the pathogenesis of the combination of this disease with Sjogren's syndrome are presented here.

引用

页码：76 / 80

页数：5

共 29 条

[1] Neuromyelitis Optica Spectrum Disorders [J].

Akaishi, Tetsuya ;

Nakashima, Ichiro ;

Sato, Douglas Kazutoshi ;

Takahashi, Toshiyuki ;

Fujihara, Kazuo .

NEUROIMAGING CLINICS OF NORTH AMERICA, 2017, 27 (02) :251-+

[2]

[Ананьева Лидия Петровна Ananieva L.P.], 2014, [Научно-практическая ревматология, Rheumatology Science and Practice, Nauchno-prakticheskaya revmatologiya], P495, DOI 10.14412/1995-4484-2014-495-506

[3] RITUXIMAB MONOTHERAPY FOR PATIENTS WITH RECURRENT PRIMARY CNS LYMPHOMA [J].